Poland· PL-100147935
Maść cynkowa
A medicinal product containing zinci oxidi unguentum, registered in Poland by Zakład Farmaceutyczny "Amara" Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Zinci oxidi unguentum
- Manufacturer
- Zakład Farmaceutyczny "Amara" Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990421183
- gtin05909990421190
- gtin05909990421275
- gtin05909990421169
- gtin05909990421206
- gtin05909990421176
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zinci oxidi unguentum in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States(Re) Setting 100% mineral Powder Deep Broad Spectrum SPF 35Supergoop, LLC
- GermanyBiolectraHermes Arzneimittel Gmbh
- United KingdomAntipeol ointmentAspar Pharmaceuticals Ltd
- BelgiumAlopateCeres Pharmaceuticals
- Japan亜鉛華小堺製薬
- NetherlandsWilzin 25 mg, harde capsulesOrphan Europe SARL
- FranceEFFIZINC 15 mg, géluleEXPANSCIENCE
- FinlandVetzin vet.Vepidan Aps
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Labisan, Zink Aguettant
- Belgium · Unguentum, Zinc Aguettant
- Germany · Biolectra, Cefazink
- Denmark · Zipzoc
- Spain · Pasta Lassar Imba
- Finland · Zipzoc
- France · Effizinc, Oligosol
- United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
- Greece · Zincalto, Zinctin
- Ireland · Caldease, Zinc Ovelle
- Iceland · Wilzin
- Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
- Liechtenstein · Wilzin
- Luxembourg · Cefazink, Oligosol
- Latvia · Cinka Rff
- Netherlands · Daro Zinkzalf, Zinkolie
- Norway · Wilzin
- Portugal · Halibut, Lassadermil
- Sweden · Zipzoc
- Slovakia · Tekutý Púder
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe390d55-055c-4295-89ff-81de82436bb6 GET /v1/drugs/fe390d55-055c-4295-89ff-81de82436bb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "10%",
"packaging": "05909990421176 ¦ OTC ¦ 29692\n1 tuba 15 g\n05909990421183 ¦ OTC ¦ 29693\n1 tuba 20 g\n05909990421190 ¦ OTC ¦ 29694\n1 tuba 25 g\n05909990421275 ¦ OTC ¦ 29695\n1 tuba 50 g\n05909990421169 ¦ OTC ¦ 56238\n1 tuba 10 g\n05909990421206 ¦ OTC ¦ 56239\n1 tuba 30 g",
"substance": "Zinci oxidum 10 g",
"common_name": "Zinci oxidi unguentum",
"pl_product_id": "100147935",
"pozwolenie_nr": "11923",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about zinci oxidi unguentum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.